Skip to content

The effect of sleep and wake training on anxiety, depression and some related hormones in infertile women

The impact of correct training sleep and wakefulness on anxiety, depression and some related hormones in infertile women referring to Hazrat Zeynab( P.B.U.H.) Hospital 2018-2019

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140622018187N8
Enrollment
130
Registered
2020-03-04
Start date
2018-05-22
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

physical and mental health.

Interventions

Intervention 1: "Intervention group: 1. Conducting a workshop, 2. Weekly follow up and completing the questionnaires 1 and 6 months after the end of the intervention, 3. 6 months after intervention".

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 44 Years

Inclusion criteria

Inclusion criteria: Poor sleep quality (greater than or equal to 5) based on the Pittsburgh questionnaire, mild depression (score less than 18) based on the Beck Depression Inventory and mild anxiety (score less than 15) based on the Beck Anxiety Inventory. Have been referred to the Infertility Center of Hazrat Zeinab Hospital for infertility treatment. Have informed consent to participate in the research and complete the relevant form Absence of mental and mental illnesses to the diagnosis of the relevant physician Absence of internal diseases to the doctor's diagnosis Absence of internal diseases to the doctor's diagnosis No stressful or disturbing event has occurred in the last 6 months Unusual situations such as traveling, changing jobs and having stressful jobs, shifting diets, and the like over the last 3 months that have caused a change in sleep patterns Not taking hormone drugs at least 4-6 weeks before blood sampling Abnormal bleeding or amenorrhea in a way that there is no possibility of bleeding on the third day of the menstrual cycle.

Exclusion criteria

Exclusion criteria: Patient dissatisfaction with continuing to participate in research at each stage Incidence of each of the 4 to 10 items listed in the inclusion criteria in each research step Pregnancy at each stage of research

Design outcomes

Primary

MeasureTime frame
Blood hormones (TSH, FSH, LH, PROLACTIN) will be measured on day 3 of the menstrual cycle. Timepoint: Blood sampling at baseline and then 6 months after the last intervention. Method of measurement: Blood sampling and hormonal testing.

Secondary

MeasureTime frame
Mental health. Timepoint: At the beginning of the study and 1 month and 6 months after the end of the intervention. Method of measurement: - Pittsburgh PSQI questionnaire- Beck Depression Inventory (BDI)- BAI Anxiety Inventory- Demographic questionnaire (including information on age, education, occupation and couple, history of infertility by type and cause, socioeconomic status, body mass index, distance from previous pregnancy (if secondary), medication use, smoking, alcohol and Tobacco and Paraclinical Tests and Records)Depression Inventory and Mild Anxiety (score less than 15) based on Beck Anxiety Inventory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSedighe Forouhari

Shiraz University of Medical Sciences

forouharism@yahoo.com+98 71 1647 4257

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026